158 related articles for article (PubMed ID: 23773507)
61. Unrelated donor BMT for Wiskott-Aldrich syndrome.
Lenarsky C; Weinberg K; Kohn DB; Parkman R
Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361
[TBL] [Abstract][Full Text] [Related]
62. Fludarabine, cyclophosphamide and horse antithymocyte globulin conditioning regimen for allogeneic peripheral blood stem cell transplantation performed in non-HEPA filter rooms for multiply transfused patients with severe aplastic anemia.
Kumar R; Prem S; Mahapatra M; Seth T; Chowdhary DR; Mishra P; Pillai L; Narendra AM; Mehra NK; Saxena R; Choudhry VP
Bone Marrow Transplant; 2006 Apr; 37(8):745-9. PubMed ID: 16518427
[TBL] [Abstract][Full Text] [Related]
63. Autologous stem cell transplantation with thiotepa, busulfan, and cyclophosphamide (TBC) conditioning in patients with CNS involvement by non-Hodgkin lymphoma.
Cote GM; Hochberg EP; Muzikansky A; Hochberg FH; Drappatz J; McAfee SL; Batchelor TT; LaCasce AS; Fisher DC; Abramson JS; Armand P; Chen YB
Biol Blood Marrow Transplant; 2012 Jan; 18(1):76-83. PubMed ID: 21749848
[TBL] [Abstract][Full Text] [Related]
64. High-dose carmustine, etoposide, and cyclophosphamide followed by allogeneic hematopoietic cell transplantation for non-Hodgkin lymphoma.
Law LY; Horning SJ; Wong RM; Johnston LJ; Laport GG; Lowsky R; Shizuru JA; Blume KG; Negrin RS; Stockerl-Goldstein KE
Biol Blood Marrow Transplant; 2006 Jul; 12(7):703-11. PubMed ID: 16785059
[TBL] [Abstract][Full Text] [Related]
65. Successful unrelated cord blood transplantation in an infant with Wiskott-Aldrich syndrome following recurrent cytomegalovirus disease.
Kaneko M; Watanabe T; Watanabe H; Kimura M; Suzuya H; Okamoto Y; Nakagawa R; Kuroda Y
Int J Hematol; 2003 Dec; 78(5):457-60. PubMed ID: 14704041
[TBL] [Abstract][Full Text] [Related]
66. [Successful treatment of a patient with Wiskott-Aldrich syndrome using hematopoietic stem cell transplantation--case report and literature review].
Yu J; Guan XM; Dai BT; Jiang LP; Su YC; Xiao JW; Liu XM; Xian Y; Xu YH; Yang XQ; Zhao XD
Zhonghua Er Ke Za Zhi; 2009 Mar; 47(3):183-8. PubMed ID: 19573431
[TBL] [Abstract][Full Text] [Related]
67. A novel mutation in Wiskott-Aldrich syndrome and successfully treated with umbilical cord blood transplantation.
Zhu X; Tang B; Zheng C; Liu H; Song K; Sun Z
Blood Cells Mol Dis; 2014 Dec; 53(4):283-5. PubMed ID: 24824128
[TBL] [Abstract][Full Text] [Related]
68. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
[TBL] [Abstract][Full Text] [Related]
69. Autoimmune thyroiditis following HLA-matched sibling hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome.
Knight T; Kotz K; Savaşan S
Pediatr Transplant; 2018 Aug; 22(5):e13222. PubMed ID: 29761856
[TBL] [Abstract][Full Text] [Related]
70. Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicity.
Braun CJ; Boztug K; Paruzynski A; Witzel M; Schwarzer A; Rothe M; Modlich U; Beier R; Göhring G; Steinemann D; Fronza R; Ball CR; Haemmerle R; Naundorf S; Kühlcke K; Rose M; Fraser C; Mathias L; Ferrari R; Abboud MR; Al-Herz W; Kondratenko I; Maródi L; Glimm H; Schlegelberger B; Schambach A; Albert MH; Schmidt M; von Kalle C; Klein C
Sci Transl Med; 2014 Mar; 6(227):227ra33. PubMed ID: 24622513
[TBL] [Abstract][Full Text] [Related]
71. Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome.
Ngwube A; Hanson IC; Orange J; Rider NL; Seeborg F; Shearer W; Noroski L; Nicholas S; Forbes L; Leung K; Sasa G; Naik S; Hegde M; Omer B; Ahmed N; Allen C; Gottschalk S; Wu MF; Liu H; Brenner M; Heslop H; Krance R; Martinez C
Biol Blood Marrow Transplant; 2018 Mar; 24(3):537-541. PubMed ID: 29196075
[TBL] [Abstract][Full Text] [Related]
72. Successful bone marrow transplantation in a Chinese boy with Wiskott-Aldrich syndrome.
Huang MT; Chou CC; Jou ST; Lin KH; Hsieh KH
Asian Pac J Allergy Immunol; 1996 Jun; 14(1):57-63. PubMed ID: 8980801
[TBL] [Abstract][Full Text] [Related]
73. Rare solid tumors in a patient with Wiskott-Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature.
Coppola E; Giardino G; Abate M; Tambaro FP; Bifano D; Toriello E; De Rosa A; Cillo F; Pignata C; Cirillo E
Front Immunol; 2023; 14():1229674. PubMed ID: 37781361
[TBL] [Abstract][Full Text] [Related]
74. [Hematopoietic stem cell transplantation for patients with Wiskott-Aldrich syndrome].
Wietstruck P MA; Zúñiga C P; Talesnik G E; Méndez R C; Barriga C F
Rev Med Chil; 2007 Jul; 135(7):917-23. PubMed ID: 17914550
[TBL] [Abstract][Full Text] [Related]
75. Get Outta Here! Addition of Mobilizing Agents to Conditioning Regimen Improves Donor Engraftment after Allogeneic Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome.
Rettig MP
Biol Blood Marrow Transplant; 2018 Jul; 24(7):1309-1311. PubMed ID: 29753160
[No Abstract] [Full Text] [Related]
76. The Phenotype and Treatment of WIP Deficiency: Literature Synopsis and Review of a Patient With Pre-transplant Serial Donor Lymphocyte Infusions to Eliminate CMV.
Schwinger W; Urban C; Ulreich R; Sperl D; Karastaneva A; Strenger V; Lackner H; Boztug K; Albert MH; Benesch M; Seidel MG
Front Immunol; 2018; 9():2554. PubMed ID: 30450104
[TBL] [Abstract][Full Text] [Related]
77. Outcomes of hematopoietic stem cell gene therapy for Wiskott-Aldrich syndrome.
Labrosse R; Chu JI; Armant MA; Everett JK; Pellin D; Kareddy N; Frelinger AL; Henderson LA; O'Connell AE; Biswas A; Coenen-van der Spek J; Miggelbrink A; Fiorini C; Adhikari H; Berry CC; Cantu VA; Fong J; Jaroslavsky J; Karadeniz DF; Li QZ; Reddy S; Roche AM; Zhu C; Whangbo JS; Dansereau C; Mackinnon B; Morris E; Koo SM; London WB; Baris S; Ozen A; Karakoc-Aydiner E; Despotovic JM; Forbes Satter LR; Saitoh A; Aizawa Y; King A; Nguyen MAT; Vu VDU; Snapper SB; Galy A; Notarangelo LD; Bushman FD; Williams DA; Pai SY
Blood; 2023 Oct; 142(15):1281-1296. PubMed ID: 37478401
[TBL] [Abstract][Full Text] [Related]
78. Successful HLA haploidentical HSCT with post-transplant cyclophosphamide in Wiskott-Aldrich syndrome.
Kreetapirom P; Hongeng S; Manuyakorn W; Anurathapan U; Pakakasama S; Sirachainan N; Andersson BS
Bone Marrow Transplant; 2017 Jun; 52(6):913-914. PubMed ID: 28287640
[No Abstract] [Full Text] [Related]
79. Use of allogeneic stem cell transplantation for moderate-severe Glanzmann thrombasthenia.
Walz A; Lenzen A; Curtis B; Canner J; Schneiderman J
Platelets; 2015; 26(7):702-4. PubMed ID: 25548835
[TBL] [Abstract][Full Text] [Related]
80. Correction of the murine Wiskott-Aldrich syndrome phenotype by hematopoietic stem cell transplantation.
Strom TS; Li X; Cunningham JM; Nienhuis AW
Blood; 2002 Jun; 99(12):4626-8. PubMed ID: 12036897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
